Attached files
| file | filename |
|---|---|
| EX-10 - EX-10.1 PROMISSORY NOTE - GOOD GAMING, INC. | hdsint8k062811ex101.htm |
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): June 20, 2011
HDS INTERNATIONAL CORP.
(Exact name of registrant as specified in its charter)
Nevada | 000-53949 | 26-3988293 |
(State or other jurisdiction | (Commission File Number) | (IRS Employer |
of Incorporation) |
| Identification Number) |
|
|
|
| GMV WIRELESS, INC. (Former name or former address, if changed since last report) 345 S. End Avenue #7P New York, NY 10280 |
|
| (Address of principal executive offices) |
|
| (212) 786-1290 |
|
| (Registrant’s Telephone Number) |
|
Copy of all Communications to:
Carrillo, Huettel & Zouvas, LLP
3033 5th Avenue, Suite 400
San Diego, CA 92103
Telephone: 619.546.6100
Fax: 619.546.6060
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
. Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
. Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
. Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
. Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
HDS International Corp.
Form 8-K
Current Report
ITEM 1.01
ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT
On June 20, 2011, HDS International Corp., a Nevada Corporation (the "Company"), executed an Unsecured Promissory Note (the "Note") to Amerisure Pharmaceuticals, LLC (“Amerisure"). Under the terms of the Note, the Company has borrowed a total of ten thousand dollars ($10,000) from Amerisure, which accrues interest at an annual rate of ten percent (10%), and is due on demand from Amerisure. The Note also contains customary events of default.
The foregoing summary description of the terms of the Note may not contain all information that is of interest to the reader. For further information regarding the terms and conditions of said Note, reference is made to the Note, which is filed hereto as Exhibit 10.1 and is incorporated herein by reference.
ITEM 2.03
CREATION OF A DIRECT FINANCIAL OBLIGATION OR AN OBLIGATION UNDER AN OFF-BALANCE SHEET ARRANGEMENT OF A REGISTRANT
The information set forth above in Item 1.01 of this Current Report on Form 8-K is incorporated herein by this reference.
ITEM 9.01
FINANCIAL STATEMENTS AND EXHIBITS
(d) | Exhibits |
Exhibit No. | Description of Exhibit |
10.1 | Promissory Note to Amerisure Pharmaceuticals, LLC dated June 20, 2011 |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Date: June 29, 2011
HDS International Corp.
By: /s/ Mark Simon
Name: Mark Simon
Title: CEO and President
2